OVERVIEW

Expert Insights into Fabry Disease: A Case-Based Exploration for Effective Disease Management is organized by Efficient LLC.

Course Opens: 12/29/2025
Course Expires: 12/29/2026

Description:
Fabry disease (FD) presents significant challenges in clinical practice, with nonspecific and heterogeneous symptoms that frequently obscure early recognition and contribute to missed or delayed diagnoses. Despite expanded availability of enzyme, genetic, and biomarker testing, inconsistent application of these tools continues to impede timely identification. Even after diagnosis, clinicians must navigate nuanced decisions around individualized treatment, monitoring strategies, and the integration of newer therapeutic options to optimize long-term outcomes.

This case-based activity is designed to explore these complexities through expert-guided discussion using a SOAP-note framework (Subjective, Objective, Assessment, and Plan). Through realistic clinical scenarios, faculty will walk learners through key considerations in recognizing diverse presentations, selecting and interpreting appropriate diagnostic evaluations, and tailoring treatment strategies based on phenotype, organ involvement, and disease trajectory. Ultimately, the program aims to help clinicians strengthen their diagnostic acumen, apply evidence-based management strategies, and deliver more timely, personalized care for individuals living with FD.

Learning Objectives:
Upon completion of this activity, the learner should be able to:

Evaluate and differentiate the diverse clinical symptoms of FD to improve diagnostic accuracy and reduce misdiagnosis.
Employ evidence-based practice patterns for screening and diagnosis of FD to facilitate early detection.
Optimize individualized treatment strategies for FD to enhance patient outcomes and quality of life.

ACCREDITATION & CREDITS

Credits:
Accreditation Statement:
This enduring activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Purdue University College of Pharmacy Office of Continuing Education and Professional Development and Efficient LLC. Purdue University, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT:
Purdue University designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHARMACISTS:
Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Purdue will award a maximum of 0.75 contact hours (0.75 CEUs) to pharmacists who participate in this knowledge-based activity.

A Certificate of Participation will be given upon completion of the activity enabling participants to register their credit with the appropriate licensing boards or associations.The American Association of Nurse Practitioners (NPs) accepts AMA PRA Category 1 Credit™ from providers accredited by the ACCME. For the purpose of recertification, the American Nurse Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits issued by providers accredited by the ACCME.

0.75 AMA PRA Category 1 Credit™

0.75 Contact Hours

0.75 CEUs

TARGET AUDIENCE

PhysicianPharmacistPhysician AssistantCardiologistsNephrologistsNeurologistsMedical GeneticistsPrimary Care PhysiciansNurse PractitionersAdvanced Practice Providers